• WHO states that pause in AstraZeneca's (AZN) COVID-19 vaccine trial show it is "well-run" trial

Market news

15 September 2020

WHO states that pause in AstraZeneca's (AZN) COVID-19 vaccine trial show it is "well-run" trial

  • Shows that they have looked at safety in "appropriate manner"

Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Open Demo Account & Personal Page
I understand and accept the Privacy Policy and agree to my name and contact details being used by TeleTrade to contact me about this.